The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation

Not Applicable

Not yet recruiting

• Conditions: Sinus Lift Augmentation

• Registration Number: NCT06626776
• Lead Sponsor: Mansoura University

Brief Summary

thirty implants will be inserted in patients seeking implantation of their lost posterior maxillary teeth (premolar and molars) with limited bone height below the floor of the maxillary sinus, secondary to sinus pneumatization. The patients will be selected from those attending the outpatient clinic of the Oral \& Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University.

1. Clinical Evaluation

• Implant stability

2. Radiographic Evaluation Vertical bone gain (VBG)

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-10
• Study Start: 2024-10-01
• Study First Submitted: 2024-10-01
• Study First Submitted QC: 2024-10-02
• Last Update Submitted: 2024-10-02
• Study First Posted: 2024-10-04
• Last Update Posted: 2024-10-04
• Primary Completion: 2025-04-01
• Study Completion: 2025-10-01

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Patent ostium of maxillary sinus.
• Patient with missing one or more posterior maxillary teeth.
• Residual bone height of 3-6 mm, measured from the crest of alveolar ridge to the floor of the maxillary sinus at the planned implant site.
• A ridge width at the site of implantation of <5mm.
• Platelets of normal range.
• Good oral hygiene.
• Patients in the age frame between 20 years and 60 years old.
• No gender preface in selection of the patients.
• A minimum crown height space of 8 mm.

Exclusion Criteria

• Active sinusitis, cyst, tumors or root tips at the planned surgical site.
• Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.
• Heavy smoking and alcoholism.
• Parafunctional habits such as bruxism and clenching.
• Signs of acute infection or pus discharge.
• Disturbed occlusion.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
implant stability	9 months	the stability of the implants will be evaluated by RFA with the Osstell Mentor device.
Vertical bone height	6 months	vertical bone height will be measured as the distance from the alveolar crest to the new sinus floor at the middle of the implant

Trial Locations

Locations (1)

MANSOURA University; 🇪🇬 Mansoura, Egypt